Gilead, US Square Off in Billion-Dollar HIV Drug Patent Trial Gilead, US Square Off in Billion-Dollar HIV Drug Patent Trial

Gilead Sciences is headed to trial in Delaware federal court this week to fight claims that it owes the US government a share of multibillion-dollar profits from its HIV-prevention drug regimen.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news